BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9825753)

  • 1. Increased production of nitric oxide stimulated by interleukin-1beta in peripheral blood mononuclear cells in patients with systemic sclerosis.
    Yamamoto T; Sawada Y; Katayama I; Nishioka K
    Br J Rheumatol; 1998 Oct; 37(10):1123-5. PubMed ID: 9825753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low levels of nitric oxide (NO) in systemic sclerosis: inducible NO synthase production is decreased in cultured peripheral blood monocyte/macrophage cells.
    Allanore Y; Borderie D; Hilliquin P; Hernvann A; Levacher M; Lemaréchal H; Ekindjian OG; Kahan A
    Rheumatology (Oxford); 2001 Oct; 40(10):1089-96. PubMed ID: 11600736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating intercellular adhesion molecule-1 in the sera of patients with systemic sclerosis: enhancement by inflammatory cytokines.
    Ihn H; Sato S; Fujimoto M; Kikuchi K; Kadono T; Tamaki K; Takehara K
    Br J Rheumatol; 1997 Dec; 36(12):1270-5. PubMed ID: 9448587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitrite production in mouse 3T3 fibroblasts by bleomycin-stimulated peripheral blood mononuclear cell factors.
    Yamamoto T; Katayama I; Nishioka K
    Clin Exp Rheumatol; 1999; 17(3):343-6. PubMed ID: 10410269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics of cytokine production in human peripheral blood mononuclear cells stimulated by LPS or infected by Borrelia.
    Janský L; Reymanová P; Kopecký J
    Physiol Res; 2003; 52(5):593-8. PubMed ID: 14535835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of cytokine production in human peripheral blood mononuclear cells stimulated by LPS or infected by Borrelia.
    Janský L; Reymanová P; Kopecký J
    Physiol Res; 2003; 52(6):593-8. PubMed ID: 14964289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic sclerosis fibroblasts show specific alterations of interferon-γ and tumor necrosis factor-α-induced modulation of interleukin 6 and chemokine ligand 2.
    Antonelli A; Fallahi P; Ferrari SM; Giuggioli D; Colaci M; Di Domenicantonio A; Ferri C
    J Rheumatol; 2012 May; 39(5):979-85. PubMed ID: 22422499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone inhibits cytokine production in PBMC from systemic sclerosis patients.
    de Almeida AR; Dantas AT; Pereira MC; Cordeiro MF; Gonçalves RSG; de Melo Rêgo MJB; da Rocha Pitta I; Duarte ALBP; da Rocha Pitta MG
    Inflammopharmacology; 2019 Aug; 27(4):723-730. PubMed ID: 31069604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosteroid inhibits chemokines production in systemic sclerosis patients.
    Dantas AT; de Almeida AR; Sampaio MCPD; Cordeiro MF; da Rocha LF; de Oliveira PSS; Pereira MC; de Melo Rego MJB; Marques CDL; da Rocha Pitta I; Duarte ALBP; da Rocha Pitta MG
    Steroids; 2017 Nov; 127():24-30. PubMed ID: 28866045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1 induces tumor necrosis factor (TNF) in human peripheral blood mononuclear cells in vitro and a circulating TNF-like activity in rabbits.
    Ikejima T; Okusawa S; Ghezzi P; van der Meer JW; Dinarello CA
    J Infect Dis; 1990 Jul; 162(1):215-23. PubMed ID: 2113076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal photochemotherapy induces the production of tumor necrosis factor-alpha by monocytes: implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis.
    Vowels BR; Cassin M; Boufal MH; Walsh LJ; Rook AH
    J Invest Dermatol; 1992 May; 98(5):686-92. PubMed ID: 1569319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmented production of transforming growth factor-beta by cultured peripheral blood mononuclear cells from patients with systemic sclerosis.
    Hasegawa M; Sato S; Takehara K
    Arch Dermatol Res; 2004 Jul; 296(2):89-93. PubMed ID: 15133694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium channel blockers differentially modulate cytokine production by peripheral blood mononuclear cells.
    Matsumori A; Nishio R; Nose Y
    Circ J; 2010 Mar; 74(3):567-71. PubMed ID: 20118567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls.
    Antonelli A; Ferri C; Ferrari SM; Mancusi C; Colaci M; Sebastiani M; Fallahi P
    Scand J Rheumatol; 2011 Nov; 40(6):453-6. PubMed ID: 21722069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro immunomodulatory effects of nicotine on Nitric Oxide, interleukin 1β and interleukin 37 production in human peripheral blood mononuclear cells (PBMC) from patients with Behçet disease.
    Ghozali N; Belguendouz H; Messaoudene D; Hadjimi Z; Ihammichene S; Chekaoui A; Benchabane S; Terahi M; Kediha I; Ali Pacha L; Touil-Boukoffa C
    Int Immunopharmacol; 2021 Dec; 101(Pt A):108189. PubMed ID: 34601327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced production of interleukin-6 (IL-6), oncostatin M and soluble IL-6 receptor by cultured peripheral blood mononuclear cells from patients with systemic sclerosis.
    Hasegawa M; Sato S; Ihn H; Takehara K
    Rheumatology (Oxford); 1999 Jul; 38(7):612-7. PubMed ID: 10461473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased production of interleukin 6 and interleukin 8 in scleroderma fibroblasts.
    Kadono T; Kikuchi K; Ihn H; Takehara K; Tamaki K
    J Rheumatol; 1998 Feb; 25(2):296-301. PubMed ID: 9489822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide-releasing agents enhance cytokine-induced tumor necrosis factor synthesis in human mononuclear cells.
    Eigler A; Sinha B; Endres S
    Biochem Biophys Res Commun; 1993 Oct; 196(1):494-501. PubMed ID: 8216333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diminished production of TWEAK by the peripheral blood mononuclear cells is associated with vascular involvement in patients with systemic sclerosis.
    Bielecki M; Kowal K; Lapinska A; Chwiecko J; Skowronski J; Sierakowski S; Chyczewski L; Kowal-Bielecka O
    Folia Histochem Cytobiol; 2009 Jan; 47(3):465-9. PubMed ID: 20164033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines.
    Leoni F; Zaliani A; Bertolini G; Porro G; Pagani P; Pozzi P; Donà G; Fossati G; Sozzani S; Azam T; Bufler P; Fantuzzi G; Goncharov I; Kim SH; Pomerantz BJ; Reznikov LL; Siegmund B; Dinarello CA; Mascagni P
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2995-3000. PubMed ID: 11867742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.